Archean Chemical Industries Limited (ACI) — Board Meeting | 30 July 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Board approved unaudited standalone and consolidated Q1 FY26 financial results.
💡 Investor Takeaway
Investors should note the approved Q1 FY26 financials and auditor's limited review confirmation.

Archean Chemical Industries approved its unaudited standalone and consolidated financial results for Q1 FY26, including a standalone profit after tax of ₹4,052.77 lakhs and consolidated profit after tax of ₹3,035.44 lakhs. The board also reviewed a limited review report from PKF Sridhar & Santhanam LLP on both standalone and consolidated results, confirming no material misstatements. The results were published per SEBI LODR regulations.

📄 View Original Announcement (PDF)

About Archean Chemical Industries Limited (ACI)

Chemicals · Chemicals & Petrochemicals · Listed on NSE

Market Cap: ₹6,634.65 Cr P/E: 62.1 ROE: 5.5% ROCE: 7.2%

View full ACI stock details →

📡 Get AI alerts when ACI files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ACI — Free

📊 More ACI filings

See all ACI filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ACI files new disclosures

Track ACI filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ACI — Free

Free account · 2 AI queries/day